UBS Group
MIRO

UBS Group’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

UBS Group’s Portfolio MIRO Stock Details MIRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,037
Closed -$3.56K – 10211
2023
Q2 		$3.56K Sell
2,037
-4,943
-71% -$6.52K ﹤0.01% 7619
2023
Q1 		$11.7K Buy
+6,980
New +$18.1K ﹤0.01% 7482
2022
Q4 		– Sell
-3,964
Closed -$17K – 11400
2022
Q3 		$17K Buy
3,964
+2,171
+121% +$7.01K ﹤0.01% 7645
2022
Q2 		$7K Sell
1,793
-462
-20% -$1.77K ﹤0.01% 8576
2022
Q1 		$9K Buy
2,255
+1,903
+541% +$7.09K ﹤0.01% 8590
2021
Q4 		$2K Buy
352
+227
+182% +$1.61K ﹤0.01% 9866
2021
Q3 		$1K Buy
+125
New +$1.18K ﹤0.01% 9315

Other funds holding MIRO

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFP
Sweet Financial Partners Fairmont, Minnesota $462M AUM 26.73% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

UBS Group's MIRO Position: Q3 2023 in Review

UBS Group sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q3 2023, closing a stake of 2,037 shares — an estimated $3.56K sold.

UBS Group first reported a position in MIRO in Q3 2021 and held it in 7 quarters. The position peaked at $17K in Q3 2022. 32 funds tracked by Wall St. Rank hold MIRO as of Q3 2023.

  • UBS Group reported no remaining Miromatrix Medical Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • UBS Group sold 2,037 Miromatrix Medical Inc. Common Stock shares in Q3 2023, an estimated $3.56K.
  • UBS Group first reported a position in Miromatrix Medical Inc. Common Stock in Q3 2021 and held it in 7 quarters.
  • UBS Group's Miromatrix Medical Inc. Common Stock position peaked at $17K in Q3 2022.
  • 32 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.